Results 91 to 100 of about 1,414 (186)

Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study

, 2019
Age-related macular degeneration (AMD) can cause irreversible vision loss leading to blindness. We aim to evaluate the efficacy and safety of intravitreal injections of 0.5 mg conbercept, a new anti-vascular endothelial growth factor (anti-VEGF) drug ...
Xu, Xun, Huang, Hengye, Ying, Guishuang, Ye, Jian, Wu, Zhifeng, Song, Yanping, Yu, Liyun, Xu, Gezhi, Dong, Xiaoguang, Chen, Xia, Ke, Zunhong, Liu, Xiaoling, Zhu, Shaoping, Shen, Yinchen, Zhang, Mingzhi, Liu, Kun, Xing, Yiqiao, Kaiser, Peter K, Rosenfeld, Philip J, Sun, Xiaodong   +19 more
core   +1 more source

Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy

, 2023
Background: The effect of intravitreal conbercept (IVC) before pars plana vitrectomy (PPV) on surgical complications in patients with proliferative diabetic retinopathy (PDR) was observed.
Jie Luan, Na Su, Zilin Sun, Yuzhi Ding, Yan Ni   +4 more
core   +1 more source

Comparative study on the efficacy of Conbercept and Aflibercept in the treatment of neovascular age-related macular degeneration

Scientific Reports
This study compares the effectiveness of Conbercept and Aflibercept in treating neovascular age-related macular degeneration (nAMD). Conducted at the First Affiliated Hospital of Chongqing Medical University's Ophthalmology Department (May 2020–May 2023),
Hao Xie, Huan Ju, Jing Lu, Xing Wang, Hui Peng   +4 more
doaj   +1 more source

Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections

, 2018
This study reports the short-term efficacy and safety of intravitreal conbercept injections for neovascularization at the disc (NVD) in patients with proliferative diabetic retinopathy (PDR).
Li-jia Zhou, Rong-ping Dai, Xiao Zhang, Chan Wu   +3 more
core   +1 more source

Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration Results from a 12-Month Randomized Phase 2 Study: AURORA Study [PDF]

, 2014
PurposeTo assess the safety and efficacy of multiple injections of 0.5 and 2.0 mg conbercept using variable dosing regimens in patients with neovascular age-related macular degeneration (AMD).DesignRandomized, double-masked, multicenter, controlled-dose,
Zhang, Junjun, Wang, Yusheng, Liu, Xiaoling, Ke, Xiao, Li, Xiaoxin, Xu, Xun, Tang, Shibo, Xu, Gezhi, Luo, Delun, Wu, Quan, Tang, Luosheng, Zhang, Feng   +11 more
core   +1 more source

Data_Sheet_1_Vitreous Inflammatory Cytokines and Chemokines, Not Altered After Preoperative Adjunctive Conbercept Injection, but Associated With Early Postoperative Macular Edema in Patients With Proliferative Diabetic Retinopathy.DOCX

, 2022
PurposeTo investigate the influence of preoperative adjunctive anti-VEGF drug (Conbercept) on vitreous inflammatory cytokines and chemokines profiles and whether those cytokines were associated with early macular edema (ME) after surgery for patients ...
Qinghuai Liu (5314640), Wenjun Zou (1858015), Zhengyu Zhang (172753), Ping Xie (112003), Zizhong Hu (659693), Bing Qin (492105), Hongyan Sun (327879), Jinxiang Zhao (8627865), Darui Huang (12187103), Aime Mugisha (12187106)   +9 more
core   +1 more source

Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions

International Journal of General Medicine, 2022
Xiaoxia Ding, Yu Wang, Bo Zou, Dongxiao Zang, Yi Hao Department of Ophthalmology, Fushun Eye Hospital, Fushun, Liaoning, People’s Republic of ChinaCorrespondence: Xiaoxia Ding, Fushun Eye Hospital, No.
Ding X, Wang Y, Zou B, Zang D, Hao Y
doaj  

The MD-equilibrated structural model of the conbercept–VEGF-A functional region: (A) side-view, (B) top-view.

, 2013
The MD-equilibrated structural model of the conbercept–VEGF-A functional region: (A) side-view, (B) top-view.
Jian Huang (7250), Xiaoxin Li (128947), Hui Wang (30400), Delun Luo (385182), Huaiyao Qiao (385183), Peng Zhou (116747), Zhigang Wu (385181), Xiao Ke (385184)   +7 more
core   +1 more source

Intravitreal Injection of Conbercept Combined with Dexamethasone for Macular Edema Following Central Retinal Vein Occlusion

Clinical Ophthalmology
Peipei Wu,1 Panpan Zhang,1 Jing Xu,1 Wenhui Ma,1 Longfei Li,2 Haifeng Xu1 1Department of Uveitis, Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, People’s Republic of China; 2College
Wu P, Zhang P, Xu J, Ma W, Li L, Xu H
doaj  

Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy

, 2017
Background To evaluate the efficacy and safety of intravitreal conbercept (KH902) as the primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy.
Feng Wen, Xiongze Zhang, Bing Liu, Miaoling Li, Lan Mi, Chengguo Zuo, Yuting Peng   +6 more
core   +1 more source